Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronextamab in Pts With R/R FL"

59 views
December 29, 2023
Comments 0
Login to view comments. Click here to Login